Valuation: MEDADVISO

Market Cap 7.65M 5.47M 4.69M 4.39M 4.01M 7.57M 524M 51.89M 20.18M 263M 20.54M 20.09M 870M P/E 2024
385x
P/E 2025 -0.76x
Enterprise Value 14.74M 10.54M 9.04M 8.45M 7.73M 14.58M 1.01B 100M 38.89M 507M 39.59M 38.73M 1.68B EV / Sales 2024
2.23x
EV / Sales 2025 0.92x
Free-Float
61.85%
Yield 2024 *
-
Yield 2025 -
Manager TitleAgeSince
Chief Executive Officer 46 06/11/2025
Director of Finance/CFO - 20/07/2025
Chief Tech/Sci/R&D Officer - 29/06/2020
Director TitleAgeSince
Director/Board Member - 09/08/2021
Chairman 67 31/03/2025
Director/Board Member 46 06/11/2025
Change 5-day change 1-year change 3-year change Capi.($)
+6.52%+8.89% - - 5.93M
+0.23%+4.25%-14.58%+33.30% 40.36B
-1.46%-3.13%-37.19%+162.82% 14.46B
+0.22%-1.50%-22.22%+63.10% 5.6B
+0.90%+19.69%+72.12% - 4.37B
+9.93%+12.94% - - 2.27B
-2.59%-3.80%+3.09%-38.07% 1.58B
-1.50%+14.13%-34.81% - 1.13B
-0.19%+10.40%+44.85%+153.66% 1.03B
-0.66%-2.49%+48.50%+60.32% 1.02B
Average +1.14%+6.94%+7.47%+72.52% 7.98B
Weighted average by Cap. +0.13%+6.12%-12.57%+65.74%

Financials

2024 2025
Net sales 122M 87.35M 74.86M 70.03M 64.03M 121M 8.36B 829M 322M 4.2B 328M 321M 13.9B 62.99M 45.06M 38.62M 36.13M 33.03M 62.33M 4.31B 428M 166M 2.17B 169M 166M 7.17B
Net income 792K 567K 486K 454K 415K 784K 54.26M 5.38M 2.09M 27.25M 2.13M 2.08M 90.15M -60.21M -43.07M -36.91M -34.53M -31.57M -59.58M -4.12B -409M -159M -2.07B -162M -158M -6.85B
Net Debt -2.97M -2.13M -1.82M -1.7M -1.56M -2.94M -204M -20.16M -7.84M -102M -7.98M -7.81M -338M 7.09M 5.07M 4.35M 4.07M 3.72M 7.02M 486M 48.13M 18.72M 244M 19.05M 18.64M 807M
Logo MEDADVISO
Adheris Health Ltd, formerly MedAdvisor Limited, is an Australia-based company engaged in offering pharmacy-driven patient engagement solutions that provide personalized patient experiences to help simplify the patient medication journey. Leveraging THRiV, a cloud-based, artificial intelligence (AI)-enabled platform, the Company enables the pharmacy with an improved pharmacy workflow and patient engagement solutions. THRiV analyzes hundreds of data points, from prescription history to socioeconomic factors, to anticipate patient needs. This technology allows the Company to deliver personalized strategies tailored to each individual. Its integrated platform provides users to manage, distribute and access medication information, including product information (PIs), consumer medicine information (CMIs) or patient leaflets (PL), instructions for use (IFUs) leaflets or videos, in real time.
Employees
-